These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34555165)

  • 1. Divergent Patterns of Antifracture Medication Use Following Fracture on Therapy: A Population-Based Cohort Study.
    Kline GA; Morin SN; Lix LM; Leslie WD
    J Clin Endocrinol Metab; 2022 Jan; 107(2):491-499. PubMed ID: 34555165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the Effect of Medication Adherence on Risk of Subsequent Fracture Among Women with a Fragility Fracture in the U.S. Medicare Population.
    Keshishian A; Boytsov N; Burge R; Krohn K; Lombard L; Zhang X; Xie L; Baser O
    J Manag Care Spec Pharm; 2017 Nov; 23(11):1178-1190. PubMed ID: 29083977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporotic fracture rate among women with at least 1 year of adherence to osteoporosis treatment.
    Modi A; Tang J; Sen S; Díez-Pérez A
    Curr Med Res Opin; 2015 Apr; 31(4):767-77. PubMed ID: 25708648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
    Leslie WD; Martineau P; Bryanton M; Lix LM
    Osteoporos Int; 2019 Jul; 30(7):1445-1453. PubMed ID: 31016351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient Outcomes in the Years After a DXA-BMD Treatment Monitoring Test: Improved Medication Adherence in Some, But Too Little Too Late.
    Kline GA; Lix LM; Leslie WD
    J Bone Miner Res; 2021 Aug; 36(8):1425-1431. PubMed ID: 34029406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009.
    Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD
    J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between osteoporosis treatment change and adherence, incident fracture, and total healthcare costs in a Medicare Advantage Prescription Drug plan.
    Ward MA; Xu Y; Viswanathan HN; Stolshek BS; Clay B; Adams JL; Kallich JD; Fine S; Saag KG
    Osteoporos Int; 2013 Apr; 24(4):1195-206. PubMed ID: 23100119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.
    Burge RT; Disch DP; Gelwicks S; Zhang X; Krege JH
    Osteoporos Int; 2017 Mar; 28(3):799-809. PubMed ID: 28028555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to treatment of primary osteoporosis and its association to fractures--the Swedish Adherence Register Analysis (SARA).
    Landfeldt E; Ström O; Robbins S; Borgström F
    Osteoporos Int; 2012 Feb; 23(2):433-43. PubMed ID: 21286686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of teriparatide adherence and persistence on fracture outcomes.
    Yu S; Burge RT; Foster SA; Gelwicks S; Meadows ES
    Osteoporos Int; 2012 Mar; 23(3):1103-13. PubMed ID: 22159748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence with bisphosphonate therapy and change in bone mineral density among women with osteoporosis or osteopenia in clinical practice.
    Weycker D; Lamerato L; Schooley S; Macarios D; Siu Woodworth T; Yurgin N; Oster G
    Osteoporos Int; 2013 Apr; 24(4):1483-9. PubMed ID: 22903292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA.
    Wilk A; Sajjan S; Modi A; Fan CP; Mavros P
    Osteoporos Int; 2014 Dec; 25(12):2777-86. PubMed ID: 25112720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to osteoporosis medications amongst Singaporean patients.
    Cheen MH; Kong MC; Zhang RF; Tee FM; Chandran M
    Osteoporos Int; 2012 Mar; 23(3):1053-60. PubMed ID: 21503813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of refracture associated with compliance and persistence with bisphosphonate therapy in Taiwan.
    Soong YK; Tsai KS; Huang HY; Yang RS; Chen JF; Wu PC; Huang KE
    Osteoporos Int; 2013 Feb; 24(2):511-21. PubMed ID: 22588182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis.
    Cotté FE; Fardellone P; Mercier F; Gaudin AF; Roux C
    Osteoporos Int; 2010 Jan; 21(1):145-55. PubMed ID: 19459025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction of an order set after hip fracture improves osteoporosis medication initiation and persistence: a population-based before-after analysis.
    Larose G; Al-Azazi S; Lix LM; Bohm E; Leslie WD
    Osteoporos Int; 2024 Oct; 35(10):1729-1736. PubMed ID: 38836945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of adherence to osteoporosis therapies with fracture, all-cause medical costs, and all-cause hospitalizations: a retrospective claims analysis of female health plan enrollees with osteoporosis.
    Halpern R; Becker L; Iqbal SU; Kazis LE; Macarios D; Badamgarav E
    J Manag Care Pharm; 2011; 17(1):25-39. PubMed ID: 21204588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population-based analysis of the post-fracture care gap 1996-2008: the situation is not improving.
    Leslie WD; Giangregorio LM; Yogendran M; Azimaee M; Morin S; Metge C; Caetano P; Lix LM
    Osteoporos Int; 2012 May; 23(5):1623-9. PubMed ID: 21476038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis treatment considerations based upon fracture history, fracture risk assessment, vertebral fracture assessment, and bone density in Canada.
    Leslie WD; Lix LM; Binkley N
    Arch Osteoporos; 2020 Jun; 15(1):93. PubMed ID: 32577922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in Trabecular Bone Score (TBS) With Antiresorptive Therapy Does Not Predict Fracture in Women: The Manitoba BMD Cohort.
    Leslie WD; Majumdar SR; Morin SN; Hans D; Lix LM
    J Bone Miner Res; 2017 Mar; 32(3):618-623. PubMed ID: 27933656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.